ribociclib
novartis,pfizer
['natalee', 'kisqali', 'caveat', 'breast', 'novartis', '$nvs', '$pfe', '$lly']
does novartis's natalee win come with caveats? hr of 0.75 but what about the subgroups? my take on the newly released #asco23 abstract on kisqali in adjuvant breast cancer: $nvs $lly $pfe
Pharma and biotech reporter, found a home at Evaluate Vantage.